← Evidence map

ArticleJournal of gastrointestinal cancer2025

FOLFIRINOX vs. Gemcitabine Nab-Paclitaxel in Pancreatic Cancer: A Real-World Single-Center Analysis of Efficacy and Safety.

Arif Mohammed Khan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 40818009